龙沙

作为一家综合解决方案供应商，龙沙致力于为大健康领域创造价值。龙沙运用科学技术，并凭借制药与生物技术及营养、特殊成分两大业务为大健康领域各市场提供服务。龙沙专注于创造健康环境、推动更健康的生活方式并通过消费者预防性保健预防疾病，及助力客户推出创新药物治疗甚至治愈严重疾病，从而改善患者的健康。

龙沙具备实力将制药专有技术应用至保健、卫生、快消品市场，乃至与我们生活环境相关的防腐与保护领域，进而惠及广大患者与消费者。

1897 年，龙沙诞生于瑞士的阿尔卑斯山脉地区，迄今已发展为一家广受尊敬的跨国企业，截至2018年底在全球拥有 100 多个生产基地和办事处以及约15,500名全职员工。2018 年，公司销售额达55亿瑞士法郎，核心业务的息税折旧摊销前利润（EBITDA）达15亿瑞士法郎。若需了解更多信息，请访问

Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through our Lonza Pharma Biotech & Nutrition segment our Lonza Specialty Ingredients segment businesses, we harness science technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier life preventing illness through consumers preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat even cure severe diseases.

Patients consumers benefit from our ability to transfer our pharma know-how to the healthcare, hygiene fast-moving consumer goods environment to the preservation protection of the world where we live.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites offices approximately 15,500 full-time employees worldwide at the end of 2018. The company generated sales of CHF 5.5 billion in 2018 with a CORE EBITDA of CHF 1.5 billion. Further information can be found at